Daniel Getts

Daniel Getts

Company: Myeloid Therapeutics

Job title: Chief Executive Officer


Leveraging RNA to Produce More Controllable Cell Therapies 1:00 pm

Controlling drug exposure through the unique pharmacokinetics of RNA-based therapies Impact of RNA-based cell therapies on minimizing manufacturing costs Exploring methods to minimize immune attack on RNA therapies to enhance their therapeutic effectRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.